Literature DB >> 21257825

Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients.

Tanya Bogoslovsky1, Maria Spatz, Aneeka Chaudhry, Dragan Maric, Marie Luby, Joseph Frank, Steven Warach.   

Abstract

BACKGROUND AND
PURPOSE: Endothelial progenitor cells (EPC) are important participants of neovascularization and are mobilized through signaling with stromal-derived factor (SDF-1α), vascular endothelial growth factor (VEGF), granulocyte colony-stimulating factor, and stem cell factor. The association between EPC levels and these growth factors (GF) in acute stroke has not been previously established. We aimed to determine the association between EPC and these GF, and to elucidate a relationship between these GF and stroke severity in acute stroke patients.
METHODS: Seventeen patients were selected from 175 patients with imaging-confirmed acute ischemic stroke. EPC were quantified using CD34, CD133, and VEGF-R2 markers. Plasma VEGF, SDF-1α, granulocyte colony-stimulating factor, and stem cell factor were determined by enzyme-linked immunosorbent assay on days 1 and 3, and brain MRI was performed at baseline and on days 1 and 5 after the stroke onset.
RESULTS: Levels of SDF-1α strongly (r=0.6) correlated with the numbers of EPC subsets CD133(+)VEFG-R2(+) (P<0.004), CD34(+)VEGF-R2(+) (P<0.01), and CD34(+)CD133(+)VEGF-R2(+) (P<0.01) on day 1. Stem cell factor strongly (r=0.5) correlated with CD133(+)VEGF-R2(+) (P<0.05). SDF-1α moderately inversely (r=-0.49) correlated with baseline diffusion-weighted imaging lesion volumes (P<0.04). Median levels of SDF-1α (1561 pg/mL) increased (P<0.04) on day 3 compared to day 1 (1379 pg/mL). Similarly, VEGF at day 3 (95 pg/mL) increased (P<0.03) compared to day 1 (64 pg/mL).
CONCLUSIONS: These results indicate that SDF-1α and stem cell factor correlate with an increase in EPC early in ischemic stroke patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257825      PMCID: PMC4751042          DOI: 10.1161/STROKEAHA.110.596007

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  48 in total

1.  Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.

Authors:  S A Rempel; S Dudas; S Ge; J A Gutiérrez
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

2.  Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction.

Authors:  Antonio Maria Leone; Sergio Rutella; Giuseppina Bonanno; Anna Maria Contemi; Daniela G de Ritis; Maria Benedetta Giannico; Antonio G Rebuzzi; Giuseppe Leone; Filippo Crea
Journal:  Int J Cardiol       Date:  2005-07-26       Impact factor: 4.164

3.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

4.  Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke.

Authors:  Martin Hasselblatt; Astrid Jeibmann; Barbara Riesmeier; David Maintz; Wolf-Rüdiger Schäbitz
Journal:  Acta Neuropathol       Date:  2006-10-18       Impact factor: 17.088

5.  Stroke-evoked angiogenesis results in a transient population of microvessels.

Authors:  Sung Wook Yu; Beth Friedman; Qun Cheng; Patrick D Lyden
Journal:  J Cereb Blood Flow Metab       Date:  2006-08-02       Impact factor: 6.200

6.  Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke.

Authors:  M Slevin; J Krupinski; A Slowik; P Kumar; A Szczudlik; J Gaffney
Journal:  Stroke       Date:  2000-08       Impact factor: 7.914

7.  Early blood-brain barrier disruption in human focal brain ischemia.

Authors:  Lawrence L Latour; Dong-Wha Kang; Mustapha A Ezzeddine; Julio A Chalela; Steven Warach
Journal:  Ann Neurol       Date:  2004-10       Impact factor: 10.422

8.  SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model.

Authors:  Ye Wang; Yubin Deng; Guang-Qian Zhou
Journal:  Brain Res       Date:  2007-12-14       Impact factor: 3.252

9.  Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.

Authors:  Konstantinos Stellos; Boris Bigalke; Harald Langer; Tobias Geisler; Annika Schad; Andreas Kögel; Florian Pfaff; Dimitrios Stakos; Peter Seizer; Iris Müller; Patrick Htun; Stephan Lindemann; Meinrad Gawaz
Journal:  Eur Heart J       Date:  2008-12-24       Impact factor: 29.983

10.  Role of angiogenesis in patients with cerebral ischemic stroke.

Authors:  J Krupinski; J Kaluza; P Kumar; S Kumar; J M Wang
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

View more
  28 in total

1.  Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.

Authors:  Paramita Ray; Sarah A Lewin; Laura Anne Mihalko; Sasha-Cai Lesher-Perez; Shuichi Takayama; Kathryn E Luker; Gary D Luker
Journal:  Biochem J       Date:  2012-03-01       Impact factor: 3.857

2.  Serum CXCL12 Levels as a Novel Predictor of Future Stroke Recurrence in Patients with Acute Ischemic Stroke.

Authors:  Xiao-Lin Gu; Lin Liu; Xiang-Dong Lu; Zhen-Rui Liu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

3.  Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke.

Authors:  Ling Mao; Ming Huang; Sheng-Cai Chen; Ya-Nan Li; Yuan-Peng Xia; Quan-Wei He; Meng-Die Wang; Yan Huang; Long Zheng; Bo Hu
Journal:  CNS Neurosci Ther       Date:  2014-03-02       Impact factor: 5.243

Review 4.  Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases.

Authors:  Hung Nguyen; David Aum; Sherwin Mashkouri; Gautam Rao; Juan Diego Vega Gonzales-Portillo; Stephanny Reyes; Cesario V Borlongan
Journal:  Expert Rev Neurother       Date:  2016-05-13       Impact factor: 4.618

Review 5.  Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Authors:  Gian Paolo Fadini; Douglas Losordo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

Review 6.  Endothelial progenitor cells: therapeutic perspective for ischemic stroke.

Authors:  Yu-Hui Zhao; Bin Yuan; Ji Chen; De-Hui Feng; Bin Zhao; Chao Qin; Yan-Fang Chen
Journal:  CNS Neurosci Ther       Date:  2012-12-11       Impact factor: 5.243

7.  Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke.

Authors:  Xuan Cheng; Ya-Jun Lian; Yun-Qing Ma; Nan-Chang Xie; Chuan-Jie Wu
Journal:  Mol Neurobiol       Date:  2016-01-16       Impact factor: 5.590

8.  Fast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxia.

Authors:  Elena Colombo; Claudio Marconi; Adriano Taddeo; Monica Cappelletti; Maria Luisa Villa; Mauro Marzorati; Simone Porcelli; Alessandra Vezzoli; Silvia Della Bella
Journal:  J Physiol       Date:  2011-12-12       Impact factor: 5.182

9.  Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.

Authors:  Yusen Chen; Bing Lu; Jinju Wang; Shuzhen Chen; Zhijun Lin; Xiaotang Ma; Yajing Liu; Bin Zhao; Yanfang Chen
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-11-22       Impact factor: 2.136

10.  Plasma CXCL12 levels as a predictor of future stroke.

Authors:  Robert C Schutt; Marie D Burdick; Robert M Strieter; Borna Mehrad; Ellen C Keeley
Journal:  Stroke       Date:  2012-10-04       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.